Back to Agenda
Session 4: Part 2
Session Chair(s)
Hakan Aribas, MD
CEO and Founder, ORION Healthcare, Turkey
Session 4: Machines Era in MI
Learning Objective : At the conclusion of this session, participants should: • Understand the market headwinds and how they can impact the Material Review Function • Understand the importance of medical-contextualized modern technologies • Learn how modern technologies can transform the Material Review Function and enable it to better meet business needs
Speaker(s)
Vilius Fokas
CEO & Co-Founder, Nexentria Inc., United States
Natural language processing in medical information and communication
Jennifer Liang, MS, MSC
Medical Information Technology & Analytics Lead, Global Medical Information, Bayer Inc., Canada
Innovative MI Solution to Engage with Customers During and Beyond the Pandemic
Sudy Vengarai
Sales Manager, Indegene, United States
Transforming the Material Review Function through modern technologies
Have an account?
